Browse the corpus

Blastomycosis 43 Plague ....59 Sporotrichosis 43 Botulism ....59 Mucormycosis 44 Tularemia.... ....59 Viral Hemorrhagic Fever. Sexua I ly Tn nsmifted I nfections Introduction. . . . . 44 TnYel Medicine Chlamydiq trqchomotis Infection . . . . 44 Introduction... Neisseria gonorrhoeae Infection. . 45 Malaria. Mycoplasmo genitalium Infection . 45 Typhoid (Enteric) Fever Clinical S5mdromes. . . . 45 Travelers'Diarrhea . . Cervicitis 45 Dengue Fever, Chikungunya, and Zika. Pelvic Inflammatory Disease . . . . 45 Hepatitis Virus Infections Urethritis 47 Rickettsial Infection . . . Epididymitis... 47 Brucellosis Anorectal Infections . 47 Japanese Encephalitis Treatment 47 Tick-Borne Encephalitis . . . . . Genital Ulcers 47 Yellow Fever. Herpes Simplex Virus 47 Syphilis 48 I nfectious Gastrci ntestina I Synd romes Chancroid and Lymphogranuloma Venereum. . 50 Overview Genital Warts 50 Campy lob acter I nfe ctio n . Shigella Infection Osteomyelitis Salmonella Infection Clinical Manifestations . 51 E s cherichia coli I nfe ction.

Blastomycosis 43 Plague ....59 Sporotrichosis 43 Botulism ....59 Mucormycosis 44 Tularemia.... ....59 Viral Hemorrhagic Fever. Sexua I ly Tn nsmifted I nfections Introduction. . . . . 44 TnYel Medicine Chlamydiq trqchomotis Infection . . . . 44 Introduction... Neisseria gonorrhoeae Infection. . 45 Malaria. Mycoplasmo genitalium Infection . 45 Typhoid (Enteric) Fever Clinical S5mdromes. . . . 45 Travelers'Diarrhea . . Cervicitis 45 Dengue Fever, Chikungunya, and Zika. Pelvic Inflammatory Disease . . . . 45 Hepatitis Virus Infections Urethritis 47 Rickettsial Infection . . . Epididymitis... 47 Brucellosis Anorectal Infections . 47 Japanese Encephalitis Treatment 47 Tick-Borne Encephalitis . . . . . Genital Ulcers 47 Yellow Fever. Herpes Simplex Virus 47 Syphilis 48 I nfectious Gastrci ntestina I Synd romes Chancroid and Lymphogranuloma Venereum. . 50 Overview Genital Warts 50 Campy lob acter I nfe ctio n . Shigella Infection Osteomyelitis Salmonella Infection Clinical Manifestations . 51 E s cherichia coli I nfe ction. Diagnosis 51 Yersinia Infection Laboratory and Imaging Studies 51 Vibno Infection Bone Biopsy 52 Clo stridioide s dfficile Infection Treatment 52 Viral Gastroenteritis Evaluation and Management of Osteomyelitis Parasitic Infection in Diabetic Foot Ulcers 52 Gior diq lamblis I nfe ction Evaluation and Management of Vertebral Cry pto sporidium Infection Osteomyelitis..... 53 Amebiasis Cyclosporo Infection Feuer of Unknown Origin Introduction 54 lnfections in Transplant Recipients Causes..... 54 Introduction. Evaluation 54 Antirejection Drugs in Transplant Recipients Posttransplantation Infections Im mu nodefi ciency Syndromes Timeline and Type of Transplant. . Introduction... 55 Specific Posttransplantation Infections . . . . Primary Immunodeficiencies 55 Prevention of Infections in Transplant Selective IgA Deficiency . 55 Recipients Common Variable Immunodeficiency . . . . 55 Abnormalities in the Complement System. 56 Hea lth Care-Assoriated lnfecions Therapy-lnduced Immunodefi ciencies 57 Epidemiolos/. . Prevention Bioterrcrism Catheter-Associated Urinary Tract Infections Introduction... 57 Diagnosis Anthrax 57 Treatment Smallpox (Variola) 57 Prevention

Diagnosis 51 Yersinia Infection Laboratory and Imaging Studies 51 Vibno Infection Bone Biopsy 52 Clo stridioide s dfficile Infection Treatment 52 Viral Gastroenteritis Evaluation and Management of Osteomyelitis Parasitic Infection in Diabetic Foot Ulcers 52 Gior diq lamblis I nfe ction Evaluation and Management of Vertebral Cry pto sporidium Infection Osteomyelitis..... 53 Amebiasis Cyclosporo Infection Feuer of Unknown Origin Introduction 54 lnfections in Transplant Recipients Causes..... 54 Introduction. Evaluation 54 Antirejection Drugs in Transplant Recipients Posttransplantation Infections Im mu nodefi ciency Syndromes Timeline and Type of Transplant. . Introduction... 55 Specific Posttransplantation Infections . . . . Primary Immunodeficiencies 55 Prevention of Infections in Transplant Selective IgA Deficiency . 55 Recipients Common Variable Immunodeficiency . . . . 55 Abnormalities in the Complement System. 56 Hea lth Care-Assoriated lnfecions Therapy-lnduced Immunodefi ciencies 57 Epidemiolos/. . Prevention Bioterrcrism Catheter-Associated Urinary Tract Infections Introduction... 57 Diagnosis Anthrax 57 Treatment Smallpox (Variola) 57 Prevention x

Surgical Site Infections . 82 Management of HIV Infection 95 Diagnosis 83 When to Initiate Treatment 95 Treatment 83 Antiretroviral Regimens 95 Prevention 83 Resistance Testing 95 Central Line-Associated Bloodstream Infections 84 Management of Pregnant Patients with HIV Infection . 96 Diagnosis 84 Treatment 84 Ulnl lnfectlons Prevention 84 InfluenzaViruses .... 97 Staphylococcus ctureus Bacteremia 85 Overview 97 Hospital-Acquired Pneumonia and Clinical Features and Evaluation 97 Ventilator-Associated Pneumonia. . . . 86 Management 98 Diagnosis 86 Novel Coronaviruses. . 98 Treatment 86 Human Herpewirus Infections 99 Prevention 86 Herpes Simplex Virus Tlpes I and2 100 Hospital-Acquired Infections Caused Varicella-Zoster Virus 100 by Multidrug-Resistant Organisms 87 Epstein-Barr Virus. 101 Human Qrtomegalovirus L0L HIU/AIDS Re-Emerging Vaccine-Preventable Viral Infections. . . LO2 Prevention 87 Pathophysiolory and Natural History 89 Sbwadshlp and Emerging f,eslstance Screening and Diagnosis . . 89 Introduction. 103 Initiation of Care 90 Antimicrobial Stewardship and the Value of Initial Evaluation and Laboratory Testing 90 Infectious Disease Consultation 103 Immunizations and Prophylaxis for Antibiotics for Antibiotic-Resistant Organisms 103 Opportunistic Infections 90 Newer Antibacterial Drugs to4 Complications of HIV Infection in the Outpatient Parenteral Antibiotic Therapy ro4 Antiretroviral Therapy Era 92 Metabolic, Kidney, and Liver Disorders 92 Blbllography ..106 Cardiovascular Disease 93 Neurocognitive Decline 93 Immune Reconstitution Inflammatory tclf-AsscsgmentTgt. . 11L

Surgical Site Infections . 82 Management of HIV Infection 95 Diagnosis 83 When to Initiate Treatment 95 Treatment 83 Antiretroviral Regimens 95 Prevention 83 Resistance Testing 95 Central Line-Associated Bloodstream Infections 84 Management of Pregnant Patients with HIV Infection . 96 Diagnosis 84 Treatment 84 Ulnl lnfectlons Prevention 84 InfluenzaViruses .... 97 Staphylococcus ctureus Bacteremia 85 Overview 97 Hospital-Acquired Pneumonia and Clinical Features and Evaluation 97 Ventilator-Associated Pneumonia. . . . 86 Management 98 Diagnosis 86 Novel Coronaviruses. . 98 Treatment 86 Human Herpewirus Infections 99 Prevention 86 Herpes Simplex Virus Tlpes I and2 100 Hospital-Acquired Infections Caused Varicella-Zoster Virus 100 by Multidrug-Resistant Organisms 87 Epstein-Barr Virus. 101 Human Qrtomegalovirus L0L HIU/AIDS Re-Emerging Vaccine-Preventable Viral Infections. . . LO2 Prevention 87 Pathophysiolory and Natural History 89 Sbwadshlp and Emerging f,eslstance Screening and Diagnosis . . 89 Introduction. 103 Initiation of Care 90 Antimicrobial Stewardship and the Value of Initial Evaluation and Laboratory Testing 90 Infectious Disease Consultation 103 Immunizations and Prophylaxis for Antibiotics for Antibiotic-Resistant Organisms 103 Opportunistic Infections 90 Newer Antibacterial Drugs to4 Complications of HIV Infection in the Outpatient Parenteral Antibiotic Therapy ro4 Antiretroviral Therapy Era 92 Metabolic, Kidney, and Liver Disorders 92 Blbllography ..106 Cardiovascular Disease 93 Neurocognitive Decline 93 Immune Reconstitution Inflammatory tclf-AsscsgmentTgt. . 11L Syndrome 93 Opportunistic Infections 93 lndex 195

Surgical Site Infections . 82 Management of HIV Infection 95 Diagnosis 83 When to Initiate Treatment 95 Treatment 83 Antiretroviral Regimens 95 Prevention 83 Resistance Testing 95 Central Line-Associated Bloodstream Infections 84 Management of Pregnant Patients with HIV Infection . 96 Diagnosis 84 Treatment 84 Ulnl lnfectlons Prevention 84 InfluenzaViruses .... 97 Staphylococcus ctureus Bacteremia 85 Overview 97 Hospital-Acquired Pneumonia and Clinical Features and Evaluation 97 Ventilator-Associated Pneumonia. . . . 86 Management 98 Diagnosis 86 Novel Coronaviruses. . 98 Treatment 86 Human Herpewirus Infections 99 Prevention 86 Herpes Simplex Virus Tlpes I and2 100 Hospital-Acquired Infections Caused Varicella-Zoster Virus 100 by Multidrug-Resistant Organisms 87 Epstein-Barr Virus. 101 Human Qrtomegalovirus L0L HIU/AIDS Re-Emerging Vaccine-Preventable Viral Infections. . . LO2 Prevention 87 Pathophysiolory and Natural History 89 Sbwadshlp and Emerging f,eslstance Screening and Diagnosis . . 89 Introduction. 103 Initiation of Care 90 Antimicrobial Stewardship and the Value of Initial Evaluation and Laboratory Testing 90 Infectious Disease Consultation 103 Immunizations and Prophylaxis for Antibiotics for Antibiotic-Resistant Organisms 103 Opportunistic Infections 90 Newer Antibacterial Drugs to4 Complications of HIV Infection in the Outpatient Parenteral Antibiotic Therapy ro4 Antiretroviral Therapy Era 92 Metabolic, Kidney, and Liver Disorders 92 Blbllography ..106 Cardiovascular Disease 93 Neurocognitive Decline 93 Immune Reconstitution Inflammatory tclf-AsscsgmentTgt. . 11L Syndrome 93 Opportunistic Infections 93 lndex 195 xl